| Dr Jonas R Te Paske, MD | |
|
920 E High St Ste 201, Charlottesville, VA 22902-4850 | |
| (434) 654-2870 | |
| Not Available |
| Full Name | Dr Jonas R Te Paske |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 920 E High St Ste 201, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780950949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101259840 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Martha Jefferson Hospital | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Martha Jefferson Medical Group Llc | 5991889081 | 181 |
News Archive
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
PeriOptixTM, one of the nation's leading providers of high quality magnification and illumination systems for medical and dental professionals, displayed its systems at the American Dental Association's 150th Annual Session on September 30 – October 4 in Honolulu, Hawaii.
Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old, following an FDA decision allowing the drug Teplizumab (anti-CD3) to be used in younger children.
› Verified 3 days ago
| Entity Name | Martha Jefferson Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275720559 PECOS PAC ID: 5991889081 Enrollment ID: O20080228000055 |
News Archive
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
PeriOptixTM, one of the nation's leading providers of high quality magnification and illumination systems for medical and dental professionals, displayed its systems at the American Dental Association's 150th Annual Session on September 30 – October 4 in Honolulu, Hawaii.
Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old, following an FDA decision allowing the drug Teplizumab (anti-CD3) to be used in younger children.
› Verified 3 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174808216 PECOS PAC ID: 8123291739 Enrollment ID: O20120627000467 |
News Archive
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
PeriOptixTM, one of the nation's leading providers of high quality magnification and illumination systems for medical and dental professionals, displayed its systems at the American Dental Association's 150th Annual Session on September 30 – October 4 in Honolulu, Hawaii.
Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old, following an FDA decision allowing the drug Teplizumab (anti-CD3) to be used in younger children.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonas R Te Paske, MD 1215 Lee St, Box 800712, Charlottesville, VA 22908-0816 Ph: (434) 924-2221 | Dr Jonas R Te Paske, MD 920 E High St Ste 201, Charlottesville, VA 22902-4850 Ph: (434) 654-2870 |
News Archive
OncoSec Medical Inc., a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. providing for the purchase by OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
PeriOptixTM, one of the nation's leading providers of high quality magnification and illumination systems for medical and dental professionals, displayed its systems at the American Dental Association's 150th Annual Session on September 30 – October 4 in Honolulu, Hawaii.
Eltrombopag significantly improves blood counts in some patients with refractory severe aplastic anemia, suggests research published in The New England Journal of Medicine.
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old, following an FDA decision allowing the drug Teplizumab (anti-CD3) to be used in younger children.
› Verified 3 days ago
Donald J. Dudley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22908 Phone: 434-924-2500 Fax: 434-244-9487 | |
Christian A. Chisholm, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-2500 Fax: 434-244-9487 | |
Jennifer Doorey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 | |
Evan Jacob Kraus, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Peter Jefferson Pkwy, Charlottesville, VA 22911 Phone: 434-977-4488 | |
Charles N. Landen Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-924-5100 Fax: 434-982-1840 | |
Dr. Linnea Rose Goodman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4100 Olympia Cir Ste 201, Charlottesville, VA 22911 Phone: 434-220-6620 Fax: 434-220-6621 | |
Bridget Mangan, CMN Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 |